This presentation and panel discussion is focused on the factors that are driving industry partnerships forward. What therapeutic areas, mechanisms of action, and target market segments are of most interest to large pharma and biotech companies? How have deal-making priorities changed? What are the areas of interest at large pharma and biotech companies. What development stage is best for partnering? What business models are biotech companies using to compete and grow in this environment? Networking and registration begin at 7 a.m., or register online here.